GenieBiome's mission is to bring health to the society by targeting and fixing gut microbiome with science. is using our unique in-house data and those from publicly available sources, we have developed proprietary machine learning algorithms to accurately identify novel microbes as non-invasive diagnostic biomarkers and potential therapeutic solutions to a variety of diseases. G-NiiB (trademark of GenieBiome) has successfully obtained exclusive license from CUHK for the invention of using multiple novel bacterial markers in stool to not only detect CRC but also precancerous lesions (i.e., adenomas), and developed the G-NiiB CRCcore stool test.精進微生物科技有限公司的使命是通過科學技術分析及修復您的腸道微生物，為社會帶來健康。我們正在使用獨特的內部數據以及可從公開渠道獲得的數據，開發了專有的機器學習算法，可以準確地將新型微生物識別為非侵入性診斷生物標記以及對多種疾病的潛在治療方案。 G-NiiB (GenieBiome的商標) 已成功獲得香港中文大學的獨家許可，使用多種在糞便中發現的新型細菌標記物，不僅可以檢測大腸癌，還可以檢測癌前病變（即腺瘤），並開發了G-NiiB CRCcore糞便測試 。

Incu-Bio

2020

Biotech

TSSSU Company